Union de Pharmacologie Scientifique Appliquée

The Union de pharmacologie scientifique appliquée (UPSA) is a French pharmaceutical group, independent from 1935 until acquisition by Bristol Myers Squibb in 1994. The company is now owned by Taisho Pharmaceutical.[1]

It was founded in Agen in 1935 by Dr Camille Bru. Following the founder's death in 1958 the group was run by his son Jean Bru until his own death 1989, and then by Jean Bru's widow Nicole Bru, née Magniez, from 1989 to 1994.[2] The Fondation Bru administers the charitable and cultural interests of the family.

On July 1, 2019, the sale of UPSA to Taisho Pharmaceutical is finalized. However, UPSA retains its status as a company and its flagship brands remain manufactured in France on its site.[3]

References
  1. Bristol-Myers Squibb Completes Divestment of UPSA
  2. Fondation Bru - Nicole Bru Archived September 6, 2013, at the Wayback Machine "Au sein d’UPSA, le docteur Nicole Bru fait preuve de détermination et d’une véritable passion pour l’innovation. Sa brillante carrière la mène au poste de directeur de la Recherche, puis à la direction de l’entreprise, au côté du docteur Jean Bru qu’elle a épousé en 1980. Lorsque ce dernier disparaît brutalement en 1989, elle est directeur général des Affaires scientifiques et de la Stratégie. Elle décide alors de prendre la relève."
  3. Bolz, Lisa (2021-09-30), "Dépêche télégraphique", Le monde à la une, Anamosa, pp. 42–48, retrieved 2022-07-25


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.